SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating whether Quanterix Corporation (NASDAQ: QTRX) or any of its executive officers violated securities laws by misrepresenting or failing to disclose material information to investors. What if I purchased Quanterix securities? If you purchased securities and suffered losses on your investment, join our investigation now: https://www.johnsonfistel.com/investigations/quanterix-corporation For more information, contact Jim Baker at ji ...

Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, Nov. 13, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Quanterix Corporation (“Quanterix” or “the Company”) (NASDAQ: QTRX) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Quanterix investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Investors are encouraged to contact ...

Quanterix Corporation (NASDAQ:QTRX) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Vandana Sriram - CFO Masoud Toloue - President and CEO Conference Call Participants Jake Allen - Goldman Sachs Sung Ji Nam - Scotiabank Kyle Mikson - Canaccord Genuity Puneet Souda - Leerink Partners Thomas DeBourcy - Nephron Research Operator Thank you for standing by. My name is Andrea and I will be your conference operator today. At this time, I would like to welcome everyone to the Quan ...

Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024 Sixth Consecutive Quarter of Double-Digit Growth Reaf irms Full Year 2024 Outlook BILLERICA, Mass. - November 12, 2024 - Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced preliminary financial results for the third quarter ended September 30, 2024 and reaffirmed its full year 2024 guidance. The Company also disclosed the need to restate certai ...

Nadya Tkach/iStock via Getty Images It has been more than nine months since we last took a look at life sciences company Quanterix Corporation (NASDAQ:QTRX). It was also the last time this smallcap company was covered here on Seeking Alpha. We concluded our last piece on this firm stating the stock was only appropriate for aggressive investors, even as the company had beaten expectations with its last two quarterly earnings reports. It is now time to circle back to Quanterix Corporation. An updated analysis ...

Quanterix Corporation (NASDAQ:QTRX) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Francis Pruell - Head, IR Masoud Toloue - President and CEO Vandana Sriram - CFO Conference Call Participants Jake Allen - Goldman Sachs Sung Ji Nam - Scotiabank Alexander Vukasin - Canaccord Genuity Operator Good day, and thank you for standing by. Welcome to the Quanterix Q2 2024 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now l ...

Quanterix Corporation (QTRX) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.16 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -8.70%. A quarter ago, it was expected that this company would post a loss of $0.33 per share when it actually produced a loss of $0.26, delivering a surprise of 21.21%. Over the last four quarters, the company has ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________ FORM 10-Q _________________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Comm ...

Exhibit 99.1 Quanterix Releases Financial Results for the Second Quarter of 2024 BILLERICA, Mass. – August 8, 2024 - Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the second quarter ended June 30, 2024. "Our research business once again delivered strong performance in the second quarter, growing double digits," said Masoud Toloue, Chief Executive Officer of Quanterix. "Demand for Simoa sensitivi ...

Zacks Consensus Estimate The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before ...